Swayampakula Ramakanth

Stock Analyst at HC Wainwright & Co.

(0)
# 4328
Out of 5,319 analysts
603
Total ratings
28.54%
Success rate
-14.68%
Average return
90 Stocks
Name Action Price Target Current % Upside Ratings Updated
IPA ImmunoPrecise Antibo...
Reiterates: Buy
5 5
0.44 1036.36% 11 Apr 11, 2025
RNXT RenovoRx
Reiterates: Buy
3 3
1.02 194.12% 2 Apr 4, 2025
EVAX Evaxion Biotech
Reiterates: Buy
14 14
1.29 985.27% 12 Apr 2, 2025
MDAI Spectral AI
Reiterates: Buy
4 4
1.25 180% 4 Apr 2, 2025
CELC Celcuity
Reiterates: Buy
27 27
10.27 162.9% 6 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
115 150
62.22 141.08% 21 Mar 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
12 12
1.94 492.78% 15 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
19 19
1.38 1276.81% 14 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 15 Mar 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
2 2
0.19 689.47% 15 Mar 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
18 13
0.65 1900% 11 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
6 1
0.39 156.41% 9 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
25 25
17.12 46.03% 18 Mar 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
6 6
1.4 328.57% 10 Mar 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
7 7
3.1 125.81% 14 Mar 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
0.96 420.83% 8 Mar 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
33 33
14.35 129.97% 7 Mar 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
8 150% 1 Mar 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
8 6
0.16 3650% 15 Mar 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
25 25
6.06 312.54% 13 Mar 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
40 40
19.53 104.81% 5 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
13 13
1.42 815.49% 7 Mar 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 24
11.65 106.01% 12 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
0.54 825.93% 14 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
8 8
0.68 1076.47% 20 Mar 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
46 46
6.46 612.07% 11 Mar 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
9 9
0.41 2095.12% 14 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
70 70
29.61 136.41% 12 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
110 110
71.67 53.48% 3 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
8 8
3.18 151.57% 14 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
60 60
41.17 45.74% 18 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
33 33
7.36 348.37% 18 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
6 6
1.15 378.26% 6 Jan 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
10 10
0.73 1269.86% 12 Dec 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3 3
n/a n/a 10 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
11 11
2.42 354.55% 11 Nov 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
1.85 170.27% 2 Nov 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
3 1
n/a n/a 4 Aug 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
1 1
n/a n/a 11 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
11 11
6.67 64.92% 8 May 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
1.55 1190.32% 1 Apr 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
n/a n/a 5 Mar 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
12 23
n/a n/a 9 Jan 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
2.56 251.56% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
28 32
n/a n/a 10 Nov 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3
n/a n/a 12 Nov 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Aug 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
5
n/a n/a 6 Jun 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
4
n/a n/a 3 May 15, 2023